Vertex (VRTX) Enters non-Exclusive Pact with Bristol-Myers (BMY) for VX-135 Phase 2
Tweet Send to a Friend
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb Company (NYSE: BMY) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE